{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:52:14Z","timestamp":1792637534997,"version":"4.5.0"},"reference-count":18,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2020,4,28]]},"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1136\/ejhpharm-2019-002183","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T21:29:03Z","timestamp":1589578143000},"page":"289-292","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Combination of ceftaroline and daptomycin as treatment for complicated osteomyelitis"],"prefix":"10.1136","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6296-4823","authenticated-orcid":false,"given":"Ana","family":"Gasc\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Castresana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8513-239X","authenticated-orcid":false,"given":"Natalia","family":"Alzueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0609-6467","authenticated-orcid":false,"given":"Marta","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"P\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitziber","family":"Echeverria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,5,15]]},"reference":[{"key":"2024052711115491000_28.5.289.1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh191"},{"key":"2024052711115491000_28.5.289.2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10096-015-2515-6","article-title":"Daptomycin for the treatment of osteomyelitis and orthopaedic device infections: real-world clinical experience from a European registry","volume":"35","author":"Malizos","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2024052711115491000_28.5.289.3","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00109-13"},{"key":"2024052711115491000_28.5.289.4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq146"},{"key":"2024052711115491000_28.5.289.5","doi-asserted-by":"publisher","DOI":"10.1592\/phco.29.11.1275"},{"key":"2024052711115491000_28.5.289.6","doi-asserted-by":"publisher","DOI":"10.1086\/518451"},{"key":"2024052711115491000_28.5.289.7","first-page":"391","article-title":"Mechanisms of resistance to daptomycin in Staphylococcus aureus","volume":"30","author":"G\u00f3mez Casanova","year":"2017","journal-title":"Rev Esp Quimioter"},{"key":"2024052711115491000_28.5.289.8","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2016.48.4.267"},{"key":"2024052711115491000_28.5.289.9","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S99046"},{"key":"2024052711115491000_28.5.289.10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/ofid\/ofx084","article-title":"Ceftaroline for severe methicillin-resistant Staphylococcus aureus infections: a systematic review","volume":"4","author":"Cosimi","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2024052711115491000_28.5.289.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2010.11.011"},{"key":"2024052711115491000_28.5.289.12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13756-018-0351-z","article-title":"Enhancing pharmacists' role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review","volume":"7","author":"Sakeena","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"2024052711115491000_28.5.289.13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01586-12"},{"key":"2024052711115491000_28.5.289.14","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku378"},{"key":"2024052711115491000_28.5.289.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2014.05.061"},{"key":"2024052711115491000_28.5.289.16","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1128\/AAC.02483-18","article-title":"Clinical data on daptomycin plus ceftaroline versus standard of care monotherapy in the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"63","author":"Geriak","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2024052711115491000_28.5.289.17","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00797-12"},{"key":"2024052711115491000_28.5.289.18","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-015-0763-0"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2019-002183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T18:12:07Z","timestamp":1716833527000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2019-002183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,15]]},"references-count":18,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,8,23]]},"published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.1136\/ejhpharm-2019-002183"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2019-002183","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,15]]}}}